Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Utilization of pion production accelerators in biomedical applications

Conference ·
OSTI ID:5703940
A discussion is presented of biomedical applications of pion-producing accelerators in a number of areas, but with emphasis on pion therapy for treatment of solid, non-metastasized malignancies. The problem of cancer management is described from the standpoint of the physicist, magnitude of the problem, and its social and economic impact. Barriers to successful treatment are identified, mainly with regard to radiation therapy. The properties and characteristics of ..pi.. mesons, first postulated on purely theoretical grounds by H. Yukawa are described. It is shown how they can be used to treat human cancer and why they appear to have dramatic advantages over conventional forms of radiation by virtue of the fact that they permit localization of energy deposition, preferentially, in the tumor volume. The Clinton P. Anderson Meson Physics Facility (LAMPF), and its operating characteristics, are briefly described, with emphasis on the biomedical channel. The design of a relatively inexpensive accelerator specifically for pion therapy is described as is also the status of clinical trials using the existing Clinton P. Anderson Meson Physics Facility. The advantages of proton over electron accelerator for the production of high quality, high intensity negative pion beams suitable for radiation therapy of malignancies is also addressed. Other current, medically related applications of LAMPF technology are also discussed.
Research Organization:
Los Alamos Scientific Lab., NM (USA)
DOE Contract Number:
W-7405-ENG-36
OSTI ID:
5703940
Report Number(s):
LA-UR-79-2905; CONF-791128-1
Country of Publication:
United States
Language:
English